Related references
Note: Only part of the references are listed.Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies
Jennifer Zeng et al.
CANCER CYTOPATHOLOGY (2020)
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Kimberly H. Allison et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
Yuqin Ding et al.
PLOS ONE (2020)
ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Nicholas C. Turner et al.
CLINICAL CANCER RESEARCH (2020)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility
Jane Guan et al.
CELL (2019)
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review
Anna Maria Militello et al.
FRONTIERS IN ONCOLOGY (2019)
Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer
Tanja Nadine Stueber et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy
Elena Ongaro et al.
FUTURE ONCOLOGY (2018)
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Linda S. Lindstrom et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Willemijne A. M. E. Schrijver et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Linda S. Lindstrom et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Willemijne A. M. E. Schrijver et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains
Wei Huang et al.
NATURE COMMUNICATIONS (2018)
MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines
Yuan-Ke Liang et al.
NPJ BREAST CANCER (2018)
18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Yingbing Wang et al.
CLINICAL CANCER RESEARCH (2017)
Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance
Kouki Tsuboi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
Jianbo Zhang et al.
CELL DEATH & DISEASE (2017)
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization
Laura Annaratone et al.
Oncotarget (2017)
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
Giulia Galli et al.
BREAST CARE (2017)
Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells
Carmela Paolillo et al.
CLINICAL CANCER RESEARCH (2017)
Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells
Angeles C. Tecalco-Cruz et al.
CELLULAR SIGNALLING (2017)
Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer
Angeles C. Tecalco-Cruz et al.
CLINICAL BREAST CANCER (2017)
Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells
Matthias Wolff et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Progesterone Receptor Signaling Mechanisms
Sandra L. Grimm et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
Siew Kuan Lim et al.
CANCER RESEARCH AND TREATMENT (2016)
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
Emma H. Allott et al.
BREAST CANCER RESEARCH (2016)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study
Xi Jin et al.
ONCOTARGET (2015)
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
Gaetano Aurilio et al.
EUROPEAN JOURNAL OF CANCER (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Lanell M. Peterson et al.
MOLECULAR IMAGING AND BIOLOGY (2014)
Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation
P. Rajbhandari et al.
ONCOGENE (2014)
The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
J. Zhu et al.
ONCOGENE (2014)
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2013)
Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications
F. Montemurro et al.
ANNALS OF ONCOLOGY (2013)
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G. Allevi et al.
BRITISH JOURNAL OF CANCER (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
Anna Babayan et al.
PLOS ONE (2013)
Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer
Sheng Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
Jeanette Dupont Jensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Liling Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Critical choices for modeling breast cancer in transgenic mouse models
Isabella Caligiuri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Palmitoylation Regulates 17β-Estradiol-Induced Estrogen Receptor-α Degradation and Transcriptional Activity
Piergiorgio La Rosa et al.
MOLECULAR ENDOCRINOLOGY (2012)
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells
G. Castoria et al.
ONCOGENE (2012)
Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells
Kwanghee Ryu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
Suzanne E. Wardell et al.
BIOCHEMICAL PHARMACOLOGY (2011)
BRCA1 Counteracts Progesterone Action by Ubiquitination Leading to Progesterone Receptor Degradation and Epigenetic Silencing of Target Promoters
Veronica Calvo et al.
CANCER RESEARCH (2011)
Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer
S. van de Ven et al.
CANCER TREATMENT REVIEWS (2011)
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
S. J. Aitken et al.
ANNALS OF ONCOLOGY (2010)
Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
Hakeemah Al-Nakhle et al.
CANCER RESEARCH (2010)
Breast Cancer Hormone Receptor Assay Results of Core Needle Biopsy and Modified Radical Mastectomy Specimens From the Same Patients
Gemma B. Uy et al.
CLINICAL BREAST CANCER (2010)
MicroRNA-27a Indirectly Regulates Estrogen Receptor α Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells
Xiangrong Li et al.
ENDOCRINOLOGY (2010)
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Alastair M. Thompson et al.
BREAST CANCER RESEARCH (2010)
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
M. Arnedos et al.
ANNALS OF ONCOLOGY (2009)
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
C. Liedtke et al.
ANNALS OF ONCOLOGY (2009)
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
C. Simmons et al.
ANNALS OF ONCOLOGY (2009)
Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
T. Hirata et al.
BRITISH JOURNAL OF CANCER (2009)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Transient cyclical methylation of promoter DNA
Sara Kangaspeska et al.
NATURE (2008)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:: BIG 1-98
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Membrane-associated estrogen receptor signaling pathways in human cancers
Richard J. Pietras et al.
CLINICAL CANCER RESEARCH (2007)
Quantitative analysis of estrogen receptor heterogeneity in breast cancer
Gina G. Chung et al.
LABORATORY INVESTIGATION (2007)
Long-term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
Ping Fan et al.
CANCER RESEARCH (2007)
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Sofia K. Gruvberger-Saal et al.
CLINICAL CANCER RESEARCH (2007)
Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy
Olivier Tacca et al.
ONCOLOGIST (2007)
Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells
Edmund C. Chang et al.
ENDOCRINOLOGY (2006)
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
Hannah M. Linden et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer
Gloria Roldan et al.
CANCER BIOLOGY & THERAPY (2006)
Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors
CJ Creighton et al.
CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
XJ Cui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Integration of the extranuclear and nuclear actions of estrogen
ER Levin
MOLECULAR ENDOCRINOLOGY (2005)
The NFκB pathway and endocrine-resistant breast cancer
Y Zhou et al.
ENDOCRINE-RELATED CANCER (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers
YM Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas
P Lal et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Impact of metastatic estrogen receptor and progesterone receptor status on survival
EE Lower et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
CK Osborne et al.
BRITISH JOURNAL OF CANCER (2004)
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway
SQ Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors:: A study of preoperative treatment
M Colleoni et al.
CLINICAL CANCER RESEARCH (2004)
Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer
YW Leu et al.
CANCER RESEARCH (2004)
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest
S Paruthiyil et al.
CANCER RESEARCH (2004)
A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-α down-regulation in breast cancer cells:: The role of nuclear factor-κB
JN Holloway et al.
MOLECULAR ENDOCRINOLOGY (2004)
Activation functions 1 and 2 of nuclear receptors:: Molecular strategies for transcriptional activation
A Wärnmark et al.
MOLECULAR ENDOCRINOLOGY (2003)
Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin pathway: Progesterone receptor as a potential indicator of growth factor activity in breast cancer
XJ Cui et al.
MOLECULAR ENDOCRINOLOGY (2003)
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
WR Miller et al.
EUROPEAN JOURNAL OF CANCER (2003)
Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a Ying Yang relationship between ERα and ERβ in mice
MK Lindberg et al.
MOLECULAR ENDOCRINOLOGY (2003)
Hypoxia induces proteasome-dependent degradation of estrogen receptor a in ZR-75 breast cancer cells
M Stoner et al.
MOLECULAR ENDOCRINOLOGY (2002)
Metabolic flare: Indicator of hormone responsiveness in advanced breast cancer
JE Mortimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of Iκ-B-α that can be inhibited by the tumor suppressor PTEN
S Pianetti et al.
ONCOGENE (2001)
Histological and biological evolution of human premalignant breast disease
DC Allred et al.
ENDOCRINE-RELATED CANCER (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
